While the search continues for specific markers to define ALT and to predict the clinical outcome in ALT associated tumours more effectively, the data presented here provide a platform to define the relationship between clinical outcome and the underlying biology of telomere maintenance in cancer. The gene discussed is GPT; the disease is cancer.